Sutro Biopharma STRO Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's software and technology licenses, net?
- Sutro Biopharma (STRO) reported software and technology licenses, net of $1.09M in Q1 2026.
- How has Sutro Biopharma's software and technology licenses, net changed year-over-year?
- Sutro Biopharma's software and technology licenses, net increased by 1180.0% year-over-year, from $85K to $1.09M.
- What is the long-term trend for Sutro Biopharma's software and technology licenses, net?
- Over 5 years (2020 to 2025), Sutro Biopharma's software and technology licenses, net has grown at a -25.3% compound annual growth rate (CAGR), from $2.12M to $495K.